https://www.selleckchem.com/pr....oducts/pyrotinib.htm
More ethanol was injected in patients with early RBBB (1.1 ± 0.4 vs. 0.8 ± 0.3ml without; p 0.05), who also showed higher mean CK release (827 ± 341 vs. 583 ± 279 U/l without; p 0.05). Pacemaker implantation during FU was necessary in 11.5% of patients with early RBBB, 3.1% with chronic RBBB, 7.7% with early LBBB and 0% with chronic LBBB (p = n.s. for BBB vs. no BB. ASA-induced RBBB is associated with a higher volume of infused ethanol and higher maximum CK release. RBBB does not adversely affect the clinical outcome or ne
Like
Comment
Share
